Holen Sie sich die Stockscreener-App
12.55
0.48%
-0.06
Vorhandelsmarkt:
12.54
-0.01
-0.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.61
Offen:
$12.58
24-Stunden-Volumen:
2.60M
Relative Volume:
0.77
Marktkapitalisierung:
$2.50B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-6.0628
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
-4.13%
1M Leistung:
-4.85%
6M Leistung:
-10.87%
1J Leistung:
-46.57%
1-Tages-Spanne:
$12.34
$12.59
1-Wochen-Bereich:
$12.26
$13.26
52-Wochen-Spanne:
$11.69
$24.86
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.55 | 2.52B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Is DENTSPLY SIRONA Inc. building a consolidation base2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Analyzing net buyer seller activity in DENTSPLY SIRONA Inc.Dividend Hike & Free Accurate Trade Setup Notifications - newser.com
Why DENTSPLY SIRONA Inc. stock attracts high net worth investors2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Is DENTSPLY SIRONA Inc. stock recession proofWeekly Market Outlook & Expert Curated Trade Setups - newser.com
Endodontics Devices Market Set to Witness Massive Growth by 2032 - openPR.com
What the charts say about DENTSPLY SIRONA Inc. today2025 Trading Volume Trends & Weekly High Return Stock Opportunities - newser.com
How DENTSPLY SIRONA Inc. (DY2) stock valuation compares with sector2025 Year in Review & Smart Money Movement Tracker - newser.com
How to read the order book for DENTSPLY SIRONA Inc.2025 AllTime Highs & Safe Entry Point Alerts - newser.com
News impact scoring models applied to DENTSPLY SIRONA Inc.Swing Trade & Community Verified Trade Alerts - newser.com
Leading vs lagging indicators on DENTSPLY SIRONA Inc. performanceWall Street Watch & Safe Capital Growth Tips - newser.com
Is now a turning point for DENTSPLY SIRONA Inc.July 2025 Short Interest & AI Based Buy and Sell Signals - newser.com
Will DENTSPLY SIRONA Inc. (DY2) stock sustain bullish trend into 2025Price Action & Stepwise Entry/Exit Trade Alerts - newser.com
Is DENTSPLY SIRONA Inc. stock a safe buy before earningsQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Why DENTSPLY SIRONA Inc. stock remains a top recommendationNew Guidance & AI Driven Stock Movement Reports - newser.com
How hedge fund analytics apply to DENTSPLY SIRONA Inc. stockWeekly Volume Report & Expert Approved Momentum Trade Ideas - newser.com
Can you recover from losses in DENTSPLY SIRONA Inc.Trend Reversal & Verified Trade Idea Suggestions - newser.com
What high frequency data says about DENTSPLY SIRONA Inc.July 2025 Closing Moves & Daily Momentum Trading Reports - newser.com
Will DENTSPLY SIRONA Inc. stock maintain growth storyTrade Ideas & Capital Efficient Trading Techniques - newser.com
Understanding DENTSPLY SIRONA Inc.’s price movement2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
Published on: 2025-11-02 22:13:55 - newser.com
Is DENTSPLY SIRONA Inc. (DY2) stock a safe buy pre earningsTrade Entry Summary & Fast Gain Stock Trading Tips - newser.com
Will DENTSPLY SIRONA Inc. (DY2) stock deliver stable dividends2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com
DENTSPLY SIRONA Inc. stock prediction for this week2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Why retail investors favor DENTSPLY SIRONA Inc. stockJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
Published on: 2025-11-01 12:01:17 - newser.com
Published on: 2025-11-01 06:10:33 - newser.com
Is DENTSPLY SIRONA Inc. stock positioned for long term growthJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-11-01 05:22:17 - newser.com
Will DENTSPLY SIRONA Inc. (DY2) stock issue positive guidanceTrade Volume Report & Reliable Volume Spike Trade Alerts - newser.com
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):